Cardiac Rehabilitation Availability and Density around the Globe.
Clicks: 306
ID: 55249
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
79.2
/100
306 views
244 readers
Trending
AI Quality Assessment
Not analyzed
Despite the epidemic of cardiovascular disease and the benefits of cardiac rehabilitation (CR), availability is known to be insufficient, although this is not quantified. This study ascertained CR availability, volumes and its drivers, and density.A survey was administered to CR programs globally. Cardiac associations and local champions facilitated program identification. Factors associated with volumes were assessed using generalized linear mixed models, and compared by World Health Organization region. Density (i.e. annual ischemic heart disease [IHD] incidence estimate from Global Burden of Disease study divided by national CR capacity) was computed.CR was available in 111/203 (54.7%) countries; data were collected in 93 (83.8% country response; N = 1082 surveys, 32.1% program response rate). Availability by region ranged from 80.7% of countries in Europe, to 17.0% in Africa (p < .001). There were 5753 programs globally that could serve 1,655,083 patients/year, despite an estimated 20,279,651 incident IHD cases globally/year. Volume was significantly greater where patients were systematically referred (odds ratio [OR] = 1.36, 95% confidence interval [CI] = 1.35-1.38) and programs offered alternative models (OR = 1.05, 95%CI = 1.04-1.06), and significantly lower with private (OR = .92, 95%CI = .91-.93) or public (OR = .83, 95%CI = .82-84) funding compared to hybrid sources.Median capacity (i.e., number of patients a program serve annually) was 246/program (Q25-Q75 = 150-390). The absolute density was one CR spot per 11 IHD cases in countries with CR, and 12 globally.CR is available in only half of countries globally. Where offered, capacity is grossly insufficient, such that most patients will not derive the benefits associated with participation.
Reference Key |
turkadawi2019cardiaceclinicalmedicine
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Turk-Adawi, Karam;Supervia, Marta;Lopez-Jimenez, Francisco;Pesah, Ella;Ding, Rongjing;Britto, Raquel R;Bjarnason-Wehrens, Birna;Derman, Wayne;Abreu, Ana;Babu, Abraham S;Santos, Claudia Anchique;Jong, Seng Khiong;Cuenza, Lucky;Yeo, Tee Joo;Scantlebury, Dawn;Andersen, Karl;Gonzalez, Graciela;Giga, Vojislav;Vulic, Dusko;Vataman, Eleonora;Cliff, Jacqueline;Kouidi, Evangelia;Yagci, Ilker;Kim, Chul;Benaim, Briseida;Estany, Eduardo Rivas;Fernandez, Rosalia;Radi, Basuni;Gaita, Dan;Simon, Attila;Chen, Ssu-Yuan;Roxburgh, Brendon;Martin, Juan Castillo;Maskhulia, Lela;Burdiat, Gerard;Salmon, Richard;Lomelí, Hermes;Sadeghi, Masoumeh;Sovova, Eliska;Hautala, Arto;Tamuleviciute-Prasciene, Egle;Ambrosetti, Marco;Neubeck, Lis;Asher, Elad;Kemps, Hareld;Eysymontt, Zbigniew;Farsky, Stefan;Hayward, Jo;Prescott, Eva;Dawkes, Susan;Santibanez, Claudio;Zeballos, Cecilia;Pavy, Bruno;Kiessling, Anna;Sarrafzadegan, Nizal;Baer, Carolyn;Thomas, Randal;Hu, Dayi;Grace, Sherry L; |
Journal | eclinicalmedicine |
Year | 2019 |
DOI | 10.1016/j.eclinm.2019.06.007 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.